LDC000067

LDC000067

Catalog Number:
L002370637APE
Mfr. No.:
APE-B4754
Price:
$260
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          LDC000067 (LDC067) is a novel specific inhibitor of CDK9 with IC50 value of 44 ± 10 nM [1].
          Cyclin-dependent kinase 9 (CDK9) is a cyclin-dependent kinase. CDK9 and cyclin T form the positive transcription elongation factor b (P-TEFb) complex for RNA polymerase II and functions by phosphorylating the C-terminal domain of the largest subunit of RNA polymerase II [1].
          LDC000067 (LDC067) is a novel and highly specific CDK9 inhibitor. LDC000067 exhibited selectivity for CDK9 over other CDKs in the range of 55-fold (vs. CDK2) to over 230-fold (vs. CDK6 and CDK7). LDC067 also inhibited transcription in a dose-dependent and ATP-competitive manner. In whole cells, LDC000067 induced the tumor suppressor protein p53 activation and apoptosis. LDC000067 also selectively reduced short-lived mRNAs, including those that encode regulators of apoptosis and proliferation such as MYC and MCL1 [1].

      • Properties
        • Alternative Name
          (3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide
          CAS Number
          1073485-20-7
          Molecular Formula
          C18H18N4O3S
          Molecular Weight
          370.43
          Purity
          98.18%
          Solubility
          insoluble in H2O; insoluble in EtOH; ≥18.52 mg/mL in DMSO
          Storage
          Desiccate at -20°C

          * For Research Use Only

      • Reference
        • 1. Perea-Resa C, Bury L, et al. "Cohesin Removal Reprograms Gene Expression upon Mitotic Entry." Mol Cell. 2020;S1097-2765(20)30044-7. PMID:32035037
          2. Azimi A, Caramuta S, et al. "Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors." Mol Syst Biol. 2018 Mar 5;14(3):e7858. PMID:29507054
          3. Yuan J, Jiang YY, et al. "Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma." Cancer Res. 2017 Dec 1;77(23):6614-6626. PMID:28951465

    We Also Recommend

    INH6

    $180

    PI-1840

    $268

    YH239-EE

    $241

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.